PRECLINICAL RATIONAL, SAFETY, AND PRELIMINARY EFFICACY RESULTS OF WEEKLY EVEROLIMUS, CARBOPLATIN AND PACLITAXEL AS AN INDUCTION THERAPY FOR PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED HEAD & NECK SQUAMOUS CELL CARCINOMA (CAPRA): A GERCOR-IRC PHASE I/II STUDY

被引：0
|
作者：
Faivre, S. [1 ]
Dreyer, C. [1 ]
Raymond, E. [1 ]
Fayette, J. [2 ]
Delord, J. P. [3 ]
Gatineau, M. [4 ]
Chibaudel, B. [5 ]
Aissat, N. [5 ]
Slimane, K. [6 ]
Le Tourneau, C. [7 ]
机构：
[1] Beaujon Univ Hosp, Oncol Dept, Clichy, France
[2] Ctr Leon Berard, F-69373 Lyon, France
[3] Ctr Claudius Regaud, Clin Res Unit, Toulouse, France
[4] Hop St Joseph, F-75674 Paris, France
[5] GERCOR IRC, Paris, France
[6] Novartis Pharmaceut, Oncol, Rueil Malmaison, France
[7] Inst Curie, Clin Trial Unit, Dept Med Oncol, Paris, France
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：334 / 334
页数：1
相关论文
共 50 条
  • [1] CAPRA: Safety, efficacy, and translational biomarkers of weekly everolimus, carboplatin, and paclitaxel as induction therapy for locally advanced head and neck squamous cell carcinoma (HNSCC)
    Raymond, Eric
    Le Tourneau, Christophe
    Gatineau, Michel
    Delord, Jean-Pierre
    Fayette, Jerome
    Dreyer, Chantal
    Tijeras-Raballand, Annemilai
    Albert, Sebastien
    Granier, Muriel
    Chibaudel, Benoist
    Hadengue, Alexandra
    Aissat, Nasredine
    Slimane, Khemaies
    Faivre, Sandrine J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck
    Haddad, R
    Posner, M
    CANCER, 2003, 97 (06) : 1589 - 1589
  • [3] Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck
    Shin, DM
    Glisson, BS
    Khuri, FR
    Lippman, SM
    Ginsberg, L
    Diaz, E
    Papadimitrakopoulou, V
    Feng, L
    Francisco, M
    Garden, A
    Kies, MS
    Myers, J
    Clayman, G
    Hong, WK
    CANCER, 2002, 95 (02) : 322 - 330
  • [4] A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck
    Enokida, Tomohiro
    Ogawa, Takenori
    Homma, Akihiro
    Okami, Kenji
    Minami, Shujiro
    Nakanome, Ayako
    Shimizu, Yasushi
    Maki, Daisuke
    Ueda, Yuri
    Fujisawa, Takao
    Motegi, Atsushi
    Ohkoshi, Akira
    Taguchi, Jun
    Ebisumoto, Koji
    Nomura, Shogo
    Okano, Susumu
    Tahara, Makoto
    CANCER MEDICINE, 2020, 9 (05): : 1671 - 1682
  • [5] Weekly Paclitaxel and Carboplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
    Ready, Neal E.
    Rathore, Ritesh
    Johnson, Tirrell T.
    Nadeem, Ahmed
    Chougule, Prakash
    Ruhl, Charles
    Radie-Keane, Kathy
    Theall, Kathy
    Wanebo, Harold J.
    Marcello, Jennifer
    Kennedy, Teresa
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (01): : 6 - 12
  • [6] Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck - Author reply
    Shin, DM
    CANCER, 2003, 97 (06) : 1590 - 1590
  • [7] Safety and efficacy of neoadjuvant chemotherapy with paclitaxel, carboplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma
    Tanaka, Ryoko
    Ueki, Yushi
    Ohshima, Shusuke
    Omata, Jo
    Yokoyama, Yusuke
    Takahashi, Takeshi
    Shodo, Ryusuke
    Yamazaki, Keisuke
    Ohtaki, Kohei
    Togashi, Takafumi
    Horii, Arata
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (08) : 1133 - 1141
  • [8] A multicenter phase II trial of paclitaxel, carboplatin and cetuximab (PCE) followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Enokida, T.
    Ogawa, T.
    Homma, A.
    Okami, K.
    Minami, S.
    Iwae, S.
    Nakanome, A.
    Shimizu, Y.
    Motegi, A.
    Maki, D.
    Ueda, Y.
    Fujisawa, T.
    Nomura, S.
    Okano, S.
    Tahara, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [9] Efficacy and safety of a cisplatin and paclitaxel induction regimen followed by chemoradiotherapy for patients with locally advanced head and neck squamous cell carcinoma
    Viana, Luciano de Souza
    de Aguiar Silva, Felipe Coelho
    dos Anjos Jacome, Alexandre Andrade
    Campelo Maia, Danielle Calheiros
    de Mattos, Marcos Duarte
    Jacinto, Alexandre Arthur
    Mamere, Augusto Elias
    Boldrini Junior, Domingos
    de Castro Capuzzo, Renato
    Santos, Carlos Roberto
    Carvalho, Andre Lopes
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E970 - E980
  • [10] Safety and efficacy of weekly versus three-weekly paclitaxel plus platinum neoadjuvant chemotherapy in patients with locally advanced squamous cell head and neck carcinoma: A pilot study
    Mathur, Akash
    Rastogi, Naincy
    Gurjar, Dinesh
    Sai, Ramkrishna
    Lakesar, Arvind
    Malhotra, Hemant
    SOUTH ASIAN JOURNAL OF CANCER, 2018, 7 (04) : 254 - 257
12345